Physician profile
Kevin W Carson
NPI 1609880715
$978.20
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $191 · 2021: $121 · 2022: $57.69 · 2023: $27.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $329.30 | 2019-2020 | |
| Intuitive Surgical, INC. | $128.62 | 2019-2020 | |
| Organogenesis INC. | $114.49 | 2019-2022 | |
| Smith+Nephew, INC. | $83.14 | 2019-2022 | |
| Kci USA, INC. | $54.45 | 2021-2023 | Prevena |
| Lemaitre Vascular, INC. | $52.49 | 2019 | |
| Integra Lifesciences Corporation | $50.79 | 2019-2020 | |
| Misonix INC | $40.96 | 2020-2021 | |
| Osiris Therapeutics INC. | $20.67 | 2019 | |
| Karl Storz Endoscopy-America | $17.51 | 2020 | |
| Silk Road Medical, INC. | $17.30 | 2020 | |
| Shire North American Group INC | $16.87 | 2019 | |
| Baudax Bio INC. | $14.15 | 2020 | |
| Focal Therapeutics, INC. | $14.05 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.93 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.